Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, is supporting key educational programs and initiatives throughout the month of ...
The American Cancer Society says about two-million people in the U.S. will be diagnosed with cancer this year. But new research suggests four things can lower your risk of dying from it. Those four ...
Alcohol is the third-leading preventable cause of cancer in the US, accounting for tens of thousands of cancer deaths per ...
Gastroesophageal reflux disease (GERD) causes heartburn and discomfort. Learn its symptoms, triggers, treatments, and how to ...
Anal cancer is a rare type of cancer that affects the anus (the opening through which stool leaves the body) or nearby areas, from the skin just outside the anus to the canal that connects the anus to ...
In today’s health headlines, we’re learning about new research advances to improve survival and quality of life for patients with esophageal cancer and how to prevent this type of cancer.
The GI Cancers Symposium revealed new therapies for specific cancer subsets and progress in chimeric antigen receptor T-cell ...
Malawi has the highest number of Esophageal Cancer cases in the world, according a study conducted by African Oesophageal ...
BeiGene ends its Phase 3 lung cancer trial for ociperlimab after a futility analysis. No new safety concerns were found, and study results will be shared later.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results